Syros Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
12 Sep 24 | BuyUS$161,240 | Jason Haas | Individual | 100,000 | US$1.68 | |
11 Sep 24 | BuyUS$160,680 | Conley Chee | Individual | 100,000 | US$1.71 | |
21 Dec 23 | BuyUS$3,999,998 | Samsara BioCapital LLC | Company | 904,977 | US$4.42 |
Insider Trading Volume
Insider Buying: SYRS insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 608,715 | 2.27% |
General Public | 4,806,028 | 17.9% |
Hedge Funds | 5,221,103 | 19.5% |
VC/PE Firms | 7,041,248 | 26.3% |
Institutions | 9,132,670 | 34.1% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 29.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
2,749,808 | US$5.4m | 0% | 0.55% | |||
2,505,013 | US$4.9m | 0% | 0.12% | |||
2,071,914 | US$4.1m | 0% | 0.01% | |||
1,786,427 | US$3.5m | 0% | 0.63% | |||
1,673,538 | US$3.3m | 0% | 0.13% | |||
1,475,651 | US$2.9m | 0.26% | 0.01% | |||
1,293,849 | US$2.5m | 0% | 0.43% | |||
968,217 | US$1.9m | 4.33% | no data | |||
865,443 | US$1.7m | 9.89% | 0.28% | |||
828,485 | US$1.6m | 0% | 0.04% | |||
531,914 | US$1.0m | 0% | 0.03% | |||
451,832 | US$885.6k | -14.5% | 0.05% | |||
427,536 | US$838.0k | 5.59% | 0.02% | |||
340,855 | US$668.1k | 0% | 0.24% | |||
285,803 | US$560.2k | 0.3% | no data | |||
278,103 | US$545.1k | 58.9% | 0.04% | |||
263,691 | US$516.8k | 70.1% | 0.01% | |||
262,373 | US$514.3k | -41.3% | no data | |||
259,189 | US$508.0k | 0.84% | no data | |||
251,270 | US$492.5k | 0% | 0.38% | |||
226,110 | US$443.2k | 2.66% | no data | |||
160,390 | US$314.4k | 0.51% | no data | |||
159,175 | US$312.0k | 0% | 0.28% | |||
135,850 | US$266.3k | 0% | 0.06% | |||
135,658 | US$265.9k | 35.5% | no data |